Transformational Role of Medical Imaging in (Radiation) Oncology

• Published in: Cancers Vol. 13; no. 11; p. 2557
• Main Authors: Coolens, Catherine, Gwilliam, Matt N., Alcaide-Leon, Paula, de Freitas Faria, Isabella Maria, Ynoe de Moraes, Fabio
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 23.05.2021; MDPI
• Subjects: Artificial intelligence; Biomarkers; Brain cancer; Brain tumors; Cancer therapies; Cognition & reasoning; Drug delivery; Immunotherapy; Magnetic resonance imaging; Medical prognosis; Metabolism; Metastases; Metastasis; Neuroimaging; Oncology; Patients; Physiology; Positron emission tomography; Quality of life; Radiation therapy; Review; Standardized tests; Tumor microenvironment; Tumors
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13112557

Onboard, real-time, imaging techniques, from the original megavoltage planar imaging devices, to the emerging combined MRI-Linear Accelerators, have brought a huge transformation in the ability to deliver targeted radiation therapies. Each generation of these technologies enables lethal doses of radiation to be delivered to target volumes with progressively more accuracy and thus allows shrinking of necessary geometric margins, leading to reduced toxicities. Alongside these improvements in treatment delivery, advances in medical imaging, e.g., PET, and MRI, have also allowed target volumes themselves to be better defined. The development of functional and molecular imaging is now driving a conceptually larger step transformation to both better understand the cancer target and disease to be treated, as well as how tumors respond to treatment. A biological description of the tumor microenvironment is now accepted as an essential component of how to personalize and adapt treatment. This applies not only to radiation oncology but extends widely in cancer management from surgical oncology planning and interventional radiology, to evaluation of targeted drug delivery efficacy in medical oncology/immunotherapy. Here, we will discuss the role and requirements of functional and metabolic imaging techniques in the context of brain tumors and metastases to reliably provide multi-parametric imaging biomarkers of the tumor microenvironment.